記事
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
デジタルデータあり（Crossref）
すぐに読む
CiNii Research
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
- 資料種別
- 記事
- 著者
- Narek Shaverdianほか
- 出版者
- Elsevier BV
- 出版年
- 2017-07
- 資料形態
- デジタル
- 掲載誌名
- The Lancet Oncology 18 7
- 掲載ページ
- p.895-903
全国の図書館の所蔵
国立国会図書館以外の全国の図書館の所蔵状況を表示します。
所蔵のある図書館から取寄せることが可能かなど、資料の利用方法は、ご自身が利用されるお近くの図書館へご相談ください
書誌情報
この資料の詳細や典拠（同じ主題の資料を指すキーワード、著者名）等を確認できます。
デジタル
- 資料種別
- 記事
- 著者標目
- 出版年月日等
- 2017-07
- 出版年（W3CDTF）
- 2017-07
- タイトル（掲載誌）
- The Lancet Oncology
- 巻号年月日等（掲載誌）
- 18 7
- 掲載巻
- 18
- 掲載号
- 7
- 掲載ページ
- 895-903
- 掲載年月日（W3CDTF）
- 2017-07
- ISSN（掲載誌）
- 14702045
- 出版事項（掲載誌）
- Elsevier BV
- 対象利用者
- 一般
- DOI
- 10.1016/s1470-2045(17)30380-7
- 作成日（W3CDTF）
- 2017-05-25
- 著作権情報
- https://www.elsevier.com/tdm/userlicense/1.0/
- 関連情報（URI）
- 参照
- Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter studyPhase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancerPD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanomaNivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung CancerRadiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumabNovel Approaches to Improve the Efficacy of Immuno-RadiotherapyImmunotherapy for sarcomasCD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer modelRationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatmentClinical burden of immune checkpoint inhibitor-induced pneumonitisMetformin combined with local irradiation provokes abscopal effects in a murine rectal cancer modelImmune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung CancerPD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal CancerEfficacy of PD-1 blockade therapy and T cell immunity in lung cancer patientsImpact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary studyBaseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancerEnhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant MelanomaReal-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter AnalysisTumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancerIndoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancerPrognostic Impact of PD-1 on Tumor-Infiltrating Lymphocytes in 433 Resected Esophageal CancersCombination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti–PD-1 Treatment Efficacy in Urothelial CarcinomaBladder preservation therapy for muscle invasive bladder cancer: the past, present and futureProgrammed cell death ligand 1 expression on monocytes is inversely correlated with tumour response to preoperative chemoradiotherapy for locally advanced rectal cancerAdding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell–Dependent Tumor ActivityThe effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancerThe role of radiotherapy in the age of immunotherapyペムブロリズマブ長期奏功後に肺胞出血を呈した肺扁平上皮癌の1例肺癌再発に対する再生検の現状：千葉県における多施設共同前向き観察研究肺癌診断コンソーシアムの試みペムブロリズマブが奏効して長期生存を得た肺紡錘細胞癌の2例免疫チェックポイント阻害薬の効果予測因子Immunotherapy in Colorectal Cancer: Current and Future Strategies
- 連携機関・データベース
- 国立情報学研究所 : CiNii Research
- 提供元機関・データベース
- CrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossref